Science
Powering forward – Genomics England’s COVID-19 response – Drug Target Review
Thorben Seeger reveals how Genomics England’s next-generation genomic research platform will play a key role in the response to COVID-19.
Posted: 11 September 2020 | Nikki Withers (Drug Target Review) | No comments yet
Genomics England has launched a next-generation genomic research platform that will play a key role in the response to COVID-19. It is hoped this research environment will transform how genomic data is made usable for global biopharma and academic scientists, providing worldclass patient data security, while enabling the flexibility required at the cutting edge of science. Nikki Withers spoke to Thorben Seeger, who…
-
General12 hours agoDreams shattered as 140 Zone RV caravan customers’ worst fears realised
-
General11 hours agoGrace Lillian Lee weaves a path from the Torres Strait to Paris
-
General14 hours agoPublisher ditches David Walliams after harassment claim
-
General14 hours agoThe Iranian-Australian community | The Spectator Australia